title: Primary care review of actinic keratosis and its therapeutic options: a global perspective.
abstract: Actinic keratosis (AK) is a common skin condition caused by long-term sun exposure that has the potential to progress to non-melanoma skin cancers. The objective of this review is to examine the therapeutic options and management of AK globally, particularly in Australia, Canada, and the United Kingdom. Despite its potentially malignant nature, general awareness of AK is low, both in the general population and in the primary health care setting, especially in countries with low incidence. There is no standard therapeutic strategy for AK; it is treated through a variety of lesion-directed or field-directed therapies or a combination of both. A variety of treatment options are used depending on the experience of the primary care physician, the pathology of the lesion, and patient factors. Studies have shown that the physicians do not always use the optimal treatment option because of a lack of knowledge. The higher incidence of AK in fair-skinned people in Australia has resulted in well-established management strategies and guidelines for its treatment, compared with countries with lower incidence. It is essential to raise the awareness of AK because of its potential to progress to invasive squamous cell carcinoma. Primary care physicians are often the first to see this condition in their patients and are perfectly placed to educate the public and raise awareness. It is therefore desirable that their education and knowledge about AK and its treatment are up to date.
authors: Beach Avenue Medical Clinic, Peachland, BC, Canada, drpchetty@gmail.com.
authors: Praven
authors: P
authors: Chetty
authors: Felix
authors: F
authors: Choi
authors: Timothy
authors: T
authors: Mitchell
references: Aust Fam Physician. 2007 Jul;36(7):539-43
references: 17619671
references: J Clin Aesthet Dermatol. 2014 Apr;7(4):35-42
references: 24765228
references: Med J Aust. 1989 Dec 4-18;151(11-12):611-3
references: 2593903
references: Br J Dermatol. 2000 Jun;142(6):1154-9
references: 10848739
references: J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):8-10
references: 10607350
references: J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S2-9
references: 23228302
references: J Eur Acad Dermatol Venereol. 2013 May;27(5):536-44
references: 23181594
references: Int J Dermatol. 2013 Sep;52(9):1063-70
references: 23962263
references: Health Educ Res. 2010 Feb;25(1):162-82
references: 19858077
references: J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S39-48
references: 23228305
references: J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):23-4
references: 10607353
references: Arch Dermatol. 1995 Feb;131(2):170-5
references: 7857113
references: Br J Cancer. 1996 Oct;74(8):1308-12
references: 8883423
references: Eur J Dermatol. 2008 Nov-Dec;18(6):651-9
references: 18955209
references: Clin Interv Aging. 2013;8:29-35
references: 23345970
references: Australas J Dermatol. 2011 Aug;52(3):195-201
references: 21834815
references: N Engl J Med. 2012 Mar 15;366(11):1010-9
references: 22417254
references: Cochrane Database Syst Rev. 2012 Dec 12;12:CD004415
references: 23235610
references: Br J Dermatol. 2007 Feb;156(2):222-30
references: 17223860
references: An Bras Dermatol. 2012 May-Jun;87(3):425-34
references: 22714759
references: JAMA Dermatol. 2013 Jun;149(6):666-70
references: 23553119
references: J Am Acad Dermatol. 2013 Jun;68(6):957-66
references: 23375456
references: J Drugs Dermatol. 2014 Jun;13(6):741-7
references: 24918567
references: Hautarzt. 2003 Jun;54(6):551-60; quiz 561-2
references: 12858853
references: J Eur Acad Dermatol Venereol. 2004 Sep;18(5):552-5
references: 15324391
references: J Clin Aesthet Dermatol. 2012 Apr;5(4):20-4
references: 22708003
references: J Drugs Dermatol. 2010 Sep;9(9):1101-8
references: 20865842
references: J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S20-7
references: 23228303
references: Int J Dermatol. 2006 Mar;45(3):272-6
references: 16533227
references: Photochem Photobiol. 1982 Feb;35(2):187-92
references: 7063544
references: J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S28-38
references: 23228304
references: Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2546-8
references: 17132769
references: J Eur Acad Dermatol Venereol. 2012 Jun;26(6):673-9
references: 22211665
references: J Drugs Dermatol. 2014 Feb;13(2):154-60
references: 24509965
references: N Engl J Med. 1993 Oct 14;329(16):1147-51
references: 8377777
references: Int J Dermatol. 2004 Sep;43(9):638-42
references: 15357741
references: J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):4-7
references: 10607349
references: Br J Dermatol. 2007 Dec;157 Suppl 2:41-6
references: 18067631